Is Medesis Pharma SA halal to invest in?

According to Musaffa's Shariah screening methodology, Medesis Pharma SA (ALMDP.PA) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Medesis Pharma SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medesis Pharma SA using these criteria to determine its compliance status.

Can Muslims buy shares of Medesis Pharma SA?

Muslim investors may consider investing in Medesis Pharma SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medesis Pharma SA classified as NOT HALAL?

Musaffa determines the Shariah status of Medesis Pharma SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medesis Pharma SA updated?

The Shariah compliance status of Medesis Pharma SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medesis Pharma SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medesis Pharma SA?

You can check the latest Shariah compliance status of Medesis Pharma SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Medesis Pharma SA ALMDP.PA

€0.35 €0.02 (4.48%) 1D

Last Updated: Mar 10, 12:00 AM·XPAR

ALMDP.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: September 13, 2024

Report Source: 2023 Annual Report

Medesis Pharma SA. Stock Analysis ALMDP.PA

France N/A Nano Cap Report: 2023 Annual

Medesis Pharma SA operates as a clinical development stage biopharmaceutical company, which engages in the research and development of orally administered molecule drugs. The company is headquartered in Baillargues, Occitanie and currently employs 10 full-time employees. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.

Key Statistics of Medesis Pharma SA (ALMDP.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.34€0.40

Today's Open

€0.34

Volume

150.61K

P/E Ratio (TTM)

52 Week Range

€0.32€0.48

Market Cap

1.77M

Avg. Volume

27.18K

Dividend Yield

Financial Metrics & Statements of Medesis Pharma SA (ALMDP.PA)

FAQ's for Medesis Pharma SA (ALMDP.PA)

According to Musaffa’s Shariah screening methodology, Medesis Pharma SA (ALMDP.PA) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.